Hemostemix's Expands its Marketing Team Focused on Sales in Florida
Newsfile·2025-08-14 13:17
A New Chance to Live Better, Longer Under Florida's Right-to-Try statute (SB 1768), physicians-including podiatrists, cardiologists, and all specialists treating pain and no-option patients suffering from PAD, CLTI, angina, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, and congestive heart failure can offer VesCell™, Hemostemix's patented ACP-01 therapy, to qualifying patients, following informed consent. Croom Lawrence, Chief Commercial Officer: With over 25 years of biotech commercial laun ...